The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland

Simon Andreasen, Sushama Varma, Nicholas Barasch, Lester D.R. Thompson, Markku Miettinen, Lisa Rooper, Edward B. Stelow, Tina K. Agander, Raja R. Seethala, Simion I. Chiosea, Preben Homøe, Irene Wessel, Stine R. Larsen, Daiva Erentaite, Justin Avery Bishop, Benedicte P. Ulhøi, Katalin Kiss, Linea C. Melchior, Jonathan R. Pollack, Robert B. West

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

The spectrum of tumors arising in the salivary glands is wide and has recently been shown to harbor a network of tumor-specific fusion genes. Acinic cell carcinoma (AciCC) is one of the more frequently encountered types of salivary gland carcinoma, but it has remained a genetic orphan until recently when a fusion between the HTN3 and MSANTD3 genes was described in one case. Neither of these 2 genes is known to be implicated in any other malignancy. This study was undertaken to investigate whether the HTN3-MSANTD3 fusion is a recurrent genetic event in AciCC and whether it is a characteristic of one of its histological variants. Of the 273 AciCCs screened, 9 cases showed rearrangement of MSANTD3 by break-apart fluorescence in situ hybridization, 2 had 1 to 2 extra signals, and 1 had gain, giving a total of 4.4% with MSANTD3 aberrations. In 6 of 7 available cases with MSANTD3 rearrangement, the HTN3-MSANTD3 fusion transcript was demonstrated with real-time polymerase chain reaction. Histologically, all fusion-positive cases were predominantly composed of serous tumor cells growing in solid sheets, with serous tumor cells expressing DOG-1 and the intercalated duct-like cell component being CK7 positive and S-100 positive in 6/9 cases. All but one case arose in the parotid gland, and none of the patients experienced a recurrence during follow-up. In contrast, the case with MSANTD3 gain metastasized to the cervical lymph nodes and lungs. In conclusion, we find the HTN3-MSANTD3 gene fusion to be a recurrent event in AciCC with prominent serous differentiation and an indolent clinical course.

Original languageEnglish (US)
Pages (from-to)489-496
Number of pages8
JournalAmerican Journal of Surgical Pathology
Volume43
Issue number4
DOIs
StatePublished - Apr 1 2019

    Fingerprint

Keywords

  • acinic cell
  • carcinoma
  • gene fusion
  • genes
  • genetics
  • HTN3-MSANTD3
  • salivary gland
  • salivary gland neoplasms

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

Andreasen, S., Varma, S., Barasch, N., Thompson, L. D. R., Miettinen, M., Rooper, L., Stelow, E. B., Agander, T. K., Seethala, R. R., Chiosea, S. I., Homøe, P., Wessel, I., Larsen, S. R., Erentaite, D., Bishop, J. A., Ulhøi, B. P., Kiss, K., Melchior, L. C., Pollack, J. R., & West, R. B. (2019). The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland. American Journal of Surgical Pathology, 43(4), 489-496. https://doi.org/10.1097/PAS.0000000000001200